What this consultation may focus on.
Interpreting pathology and receptor results
Planning treatment before or after surgery when indicated
Chemotherapy, hormone, targeted or immune-based treatment discussions
Monitoring response and treatment tolerance
Follow-up after active treatment
Decisions made from the whole clinical picture.
Breast cancer is not one single disease. Treatment can depend on stage, tumour biology, hormone-receptor status, HER2 status, general health and other factors. Medical oncology focuses on treatments that act throughout the body and works alongside breast surgery, radiation oncology, radiology and pathology when needed.
Common reasons patients seek an oncology review.
- A breast biopsy has confirmed cancer
- You have a pathology report and need to understand receptor results
- Systemic treatment is being considered before or after surgery
- Breast cancer has returned or spread and a new treatment plan is needed
Questions patients often ask.
Does every breast cancer patient need chemotherapy?
No. The need for chemotherapy depends on stage, tumour biology, receptor status and other clinical factors. Some patients may benefit from hormone therapy, targeted therapy, immunotherapy or other approaches instead of, or in addition to, chemotherapy.
What are ER, PR and HER2?
These are important tumour markers commonly reported in breast cancer pathology. They help define the cancer biology and can influence treatment options.
Can treatment be given before breast surgery?
Yes, in selected situations systemic treatment may be recommended before surgery. The decision depends on the cancer type, stage and treatment goals.